The Renin-Angiotensin System in Pancreatic Stellate Cells: Implications in the Development and Progression of Type 2 Diabetes Mellitus

  • Seung-Hyun Ko
  • Yu-Bai Ahn
  • Ki-Ho Song
  • Kun-Ho Yoon
Part of the Proteases in Biology and Disease book series (PBAD, volume 7)

Keywords

Pancreatitis Angiotensin Metformin Renin Aldosterone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Pirola RC, Wilson JS, 1998, Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut. 43: 128–133.PubMedCrossRefGoogle Scholar
  2. Apte MV, Haber PS, Darby SJ, Rodgers SC, McCaughan GW, Korsten MA, Pirola RC, Wilson JS, 1999, Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut. 44: 534–541.PubMedCrossRefGoogle Scholar
  3. Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grunert A, Adler G, 1998, Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology. 115: 421–432.PubMedCrossRefGoogle Scholar
  4. Bataller R, Sancho-Bru P, Gines P, Lora JM, Al-Garawi A, Sole M, Colmenero J, Nicolas JM, Jimenez W, Weich N, Gutierrez-Ramos JC, Arroyo V, Rodes J. 2003. Activated human hepatic stellate cells express the renin-angiotensin system andsynthesize angiotensin II. Gastroenterology 125: 117–125.PubMedCrossRefGoogle Scholar
  5. Campbell SE, Katwa LC, 1997, Angiotensin II stimulated expression of transforming growth factor-b1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol. 29: 1947–1958.PubMedCrossRefGoogle Scholar
  6. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJ, Holman RR, Turner RC, 1988, Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis:quantitative changes in the pancreas in type 2 diabetes. Diabetes Res Clin Prac. 4: 151–159.Google Scholar
  7. Cooper ME, Tikellis C, Thomas MC, 2006, Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system. Journal of Hypertension. 24(1):S57–S63.PubMedCrossRefGoogle Scholar
  8. Crandall DL, Herzlinger HE, Saunders BD, Armellino DC, Kral JG, 1994, Distribution of angiotensin II receptors in rat and human adipocytes. J Lipid Res. 35: 1378–1385.PubMedGoogle Scholar
  9. Fukushima M, Suzuki H, Seino Y, 2004, Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Research and Clinical Practice 66(Suppl1):S37–S43.PubMedCrossRefGoogle Scholar
  10. Gepts W, Lecompte PM, 1981, The pancreatic islets in diabetes. Am J Med. 70:105–115.PubMedCrossRefGoogle Scholar
  11. Giacchetti G, Sechi LA, Rilli S, Carey RM, 2005, The renin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab. 16: 120–126.PubMedCrossRefGoogle Scholar
  12. Haber PS, Keogh GW, Apte MV, Moran CS, Stewart NL, Crawford DH, Pirola RC, McCaughan GW, Ramm GA, Wilson JS, 1999, Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol. 155: 1087–1095.PubMedGoogle Scholar
  13. Hama K, Ohnishi H, Yasuda H, Ueda N, Mashima H, Satoh Y, Hanatsuka K, Kita H, Ohashi A, Tamada K, Sugano K, 2004, Angiotensin II stimulates DNA synthesis of rat pancreatic stellate cells by activating ERK through EGF receptor transactivation. Biochem Biophys Res Commun. 19;315(4): 905–911.CrossRefGoogle Scholar
  14. Hansson L, Lindholm DH, Niskanen L, Lanke J, Hedner T, Niklason A, 1999, Effects of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomized trial. Lancet. 353: 611–616PubMedCrossRefGoogle Scholar
  15. Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Chan JS, 2002, High glucose stimulates angiotensinogen gene expression via reactive oxygenspecies generation in rat kidney proximal tubular cells. Endocrinology. 143: 2975–2985.PubMedCrossRefGoogle Scholar
  16. Jaster R, 2004, Molecular regulation of pancreatic stellate cell function. Mol Cancer. 6: 1–8.Google Scholar
  17. Jaster R, Sparmann G, Emmrich J, Liebe S, 2002, Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells. Gut. 51: 579–584.PubMedCrossRefGoogle Scholar
  18. Ken S, Nobuhisa Y, Tohru T, 1979, Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects. Tohoku J Exp Med. 129:273–283.Google Scholar
  19. Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Girerd X, Jamerson K, Larochelle P, MacDonald TM, Schmieder RE, Schork MA, Stolt P, Viskoper R, Widimsky J, Zanchetti A; VALUE Trial Investigators, 2006, Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial. J Hypertens. 24: 1405–1412.PubMedCrossRefGoogle Scholar
  20. Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz P, 1985, Islet pathology and pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Path Res. 4:110–125.Google Scholar
  21. Ko SH, Kwon HS, Kim SR, Moon SD, Ahn YB, Song KH, Son HS, Cha BY, Lee KW, Son HY, Kang SK, Park CG, Lee IK, Yoon KH, 2004, Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats. Biochem Biophys Res Commun. 26: 114–122.CrossRefGoogle Scholar
  22. Ko SH, Hong OK, Kim JW, Ahn YB, Song KH, Cha BY, Son HY, Kim MJ, Jeong IK, Yoon KH, 2006, High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J Cell Biochem. 15:343–355.CrossRefGoogle Scholar
  23. Kruse ML, Hildebrand PB, Timke C, Folsch UR, Schmidt WE, 2000, TGF beta1 autocrine growth control in isolated pancreatic fibroblastoid cells/stellate cells in vitro. Regul Pept. 90(1-3): 47–52.PubMedCrossRefGoogle Scholar
  24. Kuno A, Yamada T, Masuda K, Ogawa K, Sogawa M, Nakamura S, Nakazawa T, Ohara H, Nomura T, Joh T, Shirai T, Itoh M, 2003, Angiotensin-converting enzyme inhibitor attenuates pancreas inflammation and fibrosis in male wistar Bonn/Kobori rats. Gastroenterology. 124: 1010–1019.PubMedCrossRefGoogle Scholar
  25. Leehey DJ, Singh AK, Alavi N, Singh R, 2000, Role of angiotensin II in diabetic nephropathy. Kidney Int Suppl. 77: S93–98.PubMedCrossRefGoogle Scholar
  26. Leung PS, Chan WP, Wong TP, Sernia C, 1999, Expression and localization of the renin-angiotensin system in the rat pancreas. J Endocrinol. 160: 13–19.PubMedCrossRefGoogle Scholar
  27. Leung PS, Carlsson PO, 2001, Tissue renin-angiotensin system: its expression, localization, regulation and potential role in the pancreas. J Mol Endocrinol. 26: 155–164.PubMedCrossRefGoogle Scholar
  28. Leung PS, Chappell MC, 2003, A local pancreatic renin-angiotensin system: endocrine and exocrine roles. Int J Biochem Cell Biol. 35: 838–846.PubMedCrossRefGoogle Scholar
  29. Leung PS, Carlsson PO, 2005, Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus. Pancreas. 30: 293–298.PubMedCrossRefGoogle Scholar
  30. Liberopoulos EN, Tsouli S, Mikhailidis DP, Elisaf MS, 2006, Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measures. Curr Drug Targets. 7(2):211–228.PubMedCrossRefGoogle Scholar
  31. Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S; LIFE Study Group, 2002, Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 23: 1004–1010.CrossRefGoogle Scholar
  32. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study Groupm 2006, Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 368(9548):1673–1679.PubMedCrossRefGoogle Scholar
  33. Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, Unger T, McAnulty RJ, Laurent GJ, 2004, Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol. 286:L156-L164.PubMedCrossRefGoogle Scholar
  34. Masamune A, Satoh M, Kikuta K, Sakai Y, Satoh A, Shimosegawa T, 2003, Inhibition of p38 mitogen-activated protein kinase blocks activation of rat pancreatic stellate cells. J Pharmacol Exp Ther. 304(1):8–14.PubMedCrossRefGoogle Scholar
  35. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FA, Chai SYI, 2003, The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol. 35: 901–918.PubMedCrossRefGoogle Scholar
  36. Nagashio Y, Asaumi H, Watanabe S, Nomiyama Y, Taguchi M, Tashiro M, Sugaya T, Otsuki M, 2004, Angiotensin II type 1 receptor interaction is an important regulator for the development of pancreatic fibrosis in mice. Am J Physiol Gastrointest Liver Physiol. 287: G170-G177.PubMedCrossRefGoogle Scholar
  37. Paradis V, Perlemuter G, Bonvoust F, Dargere D, Parfait B, Vidaud M, Conti M, Huet S, Ba N, Buffet C, Bedossa P, 2001, High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology. 34(4 Pt 1):738–744.PubMedCrossRefGoogle Scholar
  38. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB, 1999, Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol. 277(1 Pt 1): C1-C9.PubMedGoogle Scholar
  39. Reinehr R, Zoller S, Klonowski-Stumpe H, Kordes C, Haussinger D, 2004, Effects of angiotensin II on rat pancreatic stellate cells. Pancreas. 28: 129–137.PubMedCrossRefGoogle Scholar
  40. Ruiz-Ortega M, Egido J, 1997, Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int. 52: 1497–1510.PubMedCrossRefGoogle Scholar
  41. Ruiz-Ortega M, Lorenzo O, Ruperez M, Egido J, 2000, ACE inhibitors and AT(1) receptor antagonists-beyond the haemodynamic effect. Nephrol Dial Transplant. 15: 561–565.PubMedCrossRefGoogle Scholar
  42. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S, 2002, Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islets of Japanese type II diabetic patients. Diabetologia. 45:85–96.PubMedCrossRefGoogle Scholar
  43. Singh M, Sinsek H, 1990, Ethanol and the pancreas: current status. Gastroenterology. 98: 1051–1062.PubMedGoogle Scholar
  44. Stefan Y, Orci L, Malaisse-Lagae F, Perrelet A, Patel Y, Unger RH, 1982, Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes. 31:694–700.PubMedCrossRefGoogle Scholar
  45. Suda K, Miyano T, 1985, Bile pancreatitis. Arch Pathol Lab Med. 109: 433–436.PubMedGoogle Scholar
  46. Suda K, Mogaki M, Oyama T, Matsumoto Y, 1990, Histopathologic and immunohistochemical studies on alcoholic pancreatitis and chronic obstructive pancreatitis: special emphasis on ductal obstruction and genesis of pancreatitis. Am J Gastroenterol. 85: 271–276.PubMedGoogle Scholar
  47. Suda K, Tsukahara M, 1992, Histopathological and immunohistochemical studies on apparently uninvolved areas of pancreas in patients with acute pancreatitis. Arch Pathol Lab Med. 116: 934–937.PubMedGoogle Scholar
  48. Suda K, SHiotsu H, Nakamura T, Akai J, Nakamura T, 1994, Pancreatic fibrosis in patients with chronic alcohol abuse: Correlation with alcoholic pancreatitis. Am J Gastroenterol. 89: 2060–2062.PubMedGoogle Scholar
  49. Suda K, 2000, Pathogenesis and progression of human pancreatic fibrosis. Med Electron Microsc. 33: 200–206.PubMedCrossRefGoogle Scholar
  50. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J, 2003, Inflammation and angiotensin II. Int J Biochem Cell Biol. 35: 881–900.PubMedCrossRefGoogle Scholar
  51. Vidotti DB, Casarini DE, Cristovam PC, Leite CA, Schor N, Boim MA, 2004, High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol. 286: F1039–1045.PubMedCrossRefGoogle Scholar
  52. Vinson GP, Teja R, Ho MM, Hinson JP, Puddefoot JR, 1998, The role of the tissue renin-angiotensin system in the response of the rat adrenal to exogenous angiotensin II. J Endocrinol. 158: 153–159.PubMedCrossRefGoogle Scholar
  53. Watari N, Hotta Y, Mabuchi Y, 1982, Morphological studies on a vitamin A-storing cell and its complex with macrophage observed in mouse pancreatic tissues following excess vitamin A administration. Okajimas Folia Anat Jpn. 58: 837–858.PubMedGoogle Scholar
  54. World Health Organization (http://www.who.int/mediacentre/factsheets. Last access 15 Dec 2006)Google Scholar
  55. Wolf G, Neilson EG, 1990, Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol. 259(5 Pt 2): F768–777.PubMedGoogle Scholar
  56. Wolf G, Neilson EG, 1993, Angiotensin II as a renal growth factor. J Am Soc Nephrol. 3: 1531–1540.PubMedGoogle Scholar
  57. Wolf G, Mueller E, Stahl RA, Ziyadeh FN, 1993, Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest. 92: 1366–1372.PubMedCrossRefGoogle Scholar
  58. Yokota T, Denham W, Murayama K, Pelham C, Joehl R, Bell RH Jr, 2002, Pancreatic stellate cell activation and MMP production in experimental pancreatic fibrosis. J Surg Res. 104: 106–111.PubMedCrossRefGoogle Scholar
  59. Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, Yoo SJ, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim HS, Lee IK, Bonner-Weir S, 2003, Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab. 88:2300–2308.PubMedCrossRefGoogle Scholar
  60. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY, 2006, Epidemic obesity and type 2 diabetes in Asia. Lancet. 11:1681–1688.CrossRefGoogle Scholar
  61. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H, 2001, Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology. 34(4 Pt 1): 745–750.PubMedGoogle Scholar
  62. Yoshikawa H, Kihara Y, Taguchi M, Yamaguchi T, Nakamura H, Otsuki M, 2002, Role of TGF-beta1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol. 282: G549–558.PubMedGoogle Scholar
  63. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G, 2000, Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Eng J Med. 342:145–153CrossRefGoogle Scholar
  64. Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BHR, Zinman B, 2001, Ramipril and the development of diabetes. JAMA. 286:1882–1885PubMedCrossRefGoogle Scholar
  65. Yusuf S, Ostergren JB, Gerstein HC, Pfeffer MA, Swedberg K, Granger CB, Olofsson B, Probstfield J, McMurray JV, 2005, Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity Program Investigators, Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. Circulation. 5: 48–53.CrossRefGoogle Scholar
  66. Zhang SL, Filep JG, Hohman TC, Tang SS, Ingelfinger JR, Chan JS, 1999, Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int. 55: 454–464.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Seung-Hyun Ko
    • 1
  • Yu-Bai Ahn
    • 1
  • Ki-Ho Song
    • 1
  • Kun-Ho Yoon
    • 1
  1. 1.Division of Endocrinology & Metabolism, Department of Internal MedicineThe Catholic University of KoreaSeoulKorea

Personalised recommendations